You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (7) |
Back to Search
Molecularly targeted dual drug loaded lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-FDP-037
- By: YONG, Chul Soon (Yeungnam University, Gyeongsan-Si, Korea, Republic Of)
- Co-author(s): Jae Hee Kim: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
Hima Bindu Ruttala: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
Gyeong Jin An: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
Myung-Ja Hong: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
Jee-Heon Jeong: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
Dong Shik Kim: Hanyang University, Ansan-si, Korea, Republic Of
Han-Gon Choi: Hanyang University, Ansan-si, Korea, Republic Of
Chul Soon Yong: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
Jong Oh Kim: Yeungnam University, Gyeongsan-Si, Korea, Republic Of - Abstract:
Background
Abraxane® showed some potential limitations including hypersensitivity reactions importantly its poor colloidal stability, which results in a poor pharmacokinetic pattern in the systemic circulation.Purpose
A transferrin-anchored albumin nanoplatform with PEGylated lipid bilayers(Tf-L-APVN) was developed for the targeted co-delivery of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026